ADEL-Y04

N/A

Report date: 2023/10/10 11:41:47

Base Information

Drug NameADEL-Y04

Drug Alias NameADEL-Y04

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Apolipoprotein E

TargetsApolipoprotein E

Therapy Area/IndicationsCardiovascular DiseasesAlzheimer DiseaseDementia +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesADEL Inc

China Registration ClassN/A

Develop Information

Active CompaniesADEL Inc

Inactive CompaniesN/A

Active IndicationsCardiovascular DiseasesAlzheimer DiseaseDementia +[4]

Inactive IndicationsN/A

Other Information

ATC CodeN/A